Skip to main content
    A

    Anixa Biosciences Inc (ANIX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.55
    -0.07 (-2.67%)

    Market Cap: $91.08M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    64%(21/33)
    Avg Surprise
    +6.89%

    Upcoming Estimates

    Reports Jan 11, 2027 (est.)Period ending Oct 31, 2026
    EPS Consensus-$0.08
    Range-$0.09 - -$0.08
    5 analysts
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts
    Reports Mar 8, 2027 (est.)Period ending Jan 31, 2027
    EPS Consensus-$0.08
    Range-$0.08 - -$0.08
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.080.0%
    60d ago-$0.080.0%
    30d ago-$0.080.0%
    7d ago-$0.080.0%
    Current-$0.08
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-73.20%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio8.54xQuick Ratio8.54x
    Trading Statistics
    Beta0.45Avg Volume194.34K
    52-Week High$5.4652-Week Low$2.32

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 11.1% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 37.6, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$2.94
    SMA 20$2.98
    SMA 50$2.87
    SMA 200$2.96
    EMA 10$2.85
    EMA 20$2.91
    EMA 50$2.95
    EMA 200$3.04

    MACD

    Line: -0.05Signal: 0.01Hist: -0.07

    ADX

    ADX: 22.8+DI: 19.4-DI: 26.8

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down100.0
    PSAR$3.35

    Bollinger Bands

    Upper Band$3.48
    Lower Band$2.48
    %B Position3361%(Upper)
    Band Width0.07

    RSI (14-Day)

    Neutral
    37.6

    Momentum Oscillators

    Stoch %K3.1
    Stoch %D9.1
    Williams %R-98.9
    ROC (10d)-14.7%
    Momentum-0.44
    CCI (20d)-129.8
    MFI (14d)41.6

    Volatility Measures

    ATR (14d)$0.20(7.7%)
    StdDev (20d)0.25
    Hist Vol84.4%(High)

    Volume Flow

    VWAP$2.60
    OBV-2.3M
    AD Line-1.6M
    CMF (20d)-0.120

    Volume Metrics

    Avg Vol (20d)199.5K
    Vol Ratio0.6x
    VWMA (20d)$2.99

    Pivot Points

    R3$2.86
    R2$2.79
    R1$2.71
    Pivot Point$2.64
    S1$2.55
    S2$2.48
    S3$2.40

    Advanced Oscillators

    TSI-6.00
    Ultimate Osc29.2
    KST63.74

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about ANIX

    News

    ANIX Valuation

    ANIX Profitability: Margins, ROIC and FCF

    Anixa Biosciences (ANIX) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -73.2%
    ANIX financial statements

    Anixa Biosciences Competitors

    The companies most similar to Anixa Biosciences (ANIX) include XBiotech, Immunic and Codexis.

    Sector: Healthcare

    Companies most similar to Anixa Biosciences

    ANIX Analyst Ratings

    Anixa Biosciences (ANIX) has a Buy consensus from 4 analysts: 4 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    4
    Strong Buy
    1
    Buy
    3
    Hold
    0
    Sell
    0
    Strong Sell
    0
    ANIX stock forecast

    ANIX Bull Case vs Bear Case

    Bull case

    • ANIX beat EPS estimates in 75.0% of its last 8 reported quarters.

    ANIX Earnings: Beat Rate and Next Report

    Anixa Biosciences (ANIX) beat the EPS estimate in 6 of the last 8 quarters (75.0%). Its next report is expected on Jan 11, 2027.

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    12.9%
    EPS estimate (fiscal period ending Oct 31, 2026)
    -$0.08
    ANIX earnings history

    ANIX Earnings Date

    ANIX reports Jan 11, 2027. The date is estimated.

    ANIX ETF Holders

    See insider activity

    Updated Sep 9, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About ANIX

    When does ANIX report earnings?

    Anixa Biosciences Inc (ANIX) is expected to report earnings on Jan 11, 2027.

    Does ANIX pay dividends?

    Anixa Biosciences Inc (ANIX) does not currently pay a regular dividend.

    What is ANIX's market cap?

    Anixa Biosciences Inc (ANIX) has a market capitalization of $91.08M with a current stock price of $2.55.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.